Element Biosciences Stock

elementbiosciences.comHealthcareFounded: 2017Funding to Date: $407.92MM

Element Biosciences developing disruptive DNA sequencing technology for research and diagnostic markets to empower customers with affordable high-quality data and an improved user experience.

Register for Details

For more details on financing and valuation for Element Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Element Biosciences.

Register Today

Other companies like Element Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

The San Diego-based startup plans to address the US research market with its Aviti short-read sequencing platform and Avidity sequencing chemistry.
The collaborations will make the Aviti platform compatible with NGS products from Roche, Agilent Technologies, New England Biolabs, Qiagen, and Watchmaker Genomics.